Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001415889-25-021522

CHIEF FINANCIAL OFFICER sold 8,000 shares

  • CHIEF FINANCIAL OFFICER acquired 2,954 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BJERKHOLT ERIC CHIEF FINANCIAL OFFICER 2025-08-11 Sale −8,000 28,236 D
BJERKHOLT ERIC CHIEF FINANCIAL OFFICER 2025-08-12 Option exercise +2,954 $26.49 $78,251 31,190 D
Derivatives
BJERKHOLT ERIC CHIEF FINANCIAL OFFICER 2025-08-12 Option exercise · Employee Stock Option (right to buy) −2,954 29,046 D
Open-market sales · 8,000 sh
Loading xslF345X05/form4-08122025_110857.xml…